myriad genetics stock analysis

Find the latest analyst research for Myriad Genetics Inc. Be The First To Find Out About The Next Big Stock.

Mygn Stock Price And Chart Nasdaq Mygn Tradingview

Myriad Genetics Stock analysis including Myriad Genetics investment evaluation stock information alerts predictive tools such as market volatility and liquidity estimators and more.

. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies. Ad Investment Analysis Software Designed For The Way You Work Built On Data And Research. Start Your Free Trial.

See a free in-depth analysis of MYGN stock including forecasts from trusted sources. Find a Dedicated Financial Advisor Now. Shares of NASDAQ MYGN opened at 2258 on Wednesday.

Health Myriad Genetics Stock Is Tanking After Earnings. Ad Myriad Genetics MyRisk Hereditary Cancer Test helps you understand your own cancer risk. The Myriad Genetics stock price gained 098 on the last trading day Monday 15th Aug 2022 rising from 2761 to 2788.

Get accurate information about genetic testing and your potential risk from Myriad. MYGN stock analysis from Seeking Alphas top analysts. Exclusive research and insights from bulls and bears.

6 2020 at 636 am. Myriad Genetics Inc. Salt Lake City UT 84108.

Zacks is the leading investment research firm focusing on stock research analysis and recommendations. MYGN Myriad Genetics - Stock quote performance technical chart analysis SmartSelect Ratings Group Leaders and the latest company headlines. Review the latest analysis on Myriad Genetics Inc MYGNXNAS stock to find out if this stock is best investment for you based on Morningstars analysis.

Get accurate information about genetic testing and your potential risk from Myriad. Find the average price target expert sentiment charts stats. Free Stock Analysis Report.

ET by Tomi Kilgore. The latest indifference towards the small price fluctuations of MYRIAD GENETICS DL may encourage shareholders to take a closer look at the firm as it is trading at a share price of 00. We Take The Complication Out Of Stock Trading So You Can Easily Profit.

Year-over-year quarterly sales growth most recently was -53. The company has a market cap of 182 billion a PE ratio of -9408 and a beta of 170. The company has a market cap of 182 billion a price-to-earnings ratio of -9408 and.

Try Out Our All-In-One Web-Based Platform For Modern Advisors. T 1 801 584. And has now gained 3 days in a rowIt will be.

The stock has a fifty day moving average price of 2314 and a 200 day moving average price of 2280. Ad Myriad Genetics MyRisk Hereditary Cancer Test helps you understand your own cancer risk. Ad Stock Research Trading Tools Designed for New Experienced Traders.

Myriad Genetics Stock Down 09. Myriad Genetics Inc a genetic testing and precision medicine company develops and commercializes genetic tests in the United States and internationally. Ad Our Team Of 20 Analysts Get Results.

Ad Do Your Investments Align with Your Goals. Has a 12 month low of 1602 and a 12 month high of. Shares of NASDAQMYGN opened at 2258 on Wednesday.

Myriad Genetics Inc. Myriad Genetics Incs trailing 12-month revenue is 6723 million with a -26 profit margin. Myriad Genetics stock price target cut to 14 from 17 at JP.

Find the latest Myriad Genetics Inc. New Reason To Talk To A Financial Advisor. Has a 12 month low of 1602 and a 12 month high of 3695.

Shares of Myriad Genetics stock opened at 2258 on Wednesday.

Mygn Stock Price And Chart Nasdaq Mygn Tradingview